drugset / Trial / NCT01538940
Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand
Phase 4
Completed
415 enrolled
Centers for Disease Control and Prevention
Ministry of Health, Thailand · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This study will assess the efficacy of a new intradermal formulation of the trivalent inactivated influenza vaccine compared to the standard intramuscular vaccine in HIV-infected men who have sex with men in Bangkok, Thailand. Relative efficacy of the two different formulations of influenza vaccine will be assessed by comparing immunologic responses to vaccine between the two study arms.
Timeline
- Start
- 2011-11-01
- Primary completion
- 2013-09-09
- Completion
- 2015-10
Outcome
Missed primary endpoint
paper Percentage of seroconversion to all (ID 14% vs IM 15%; P = .8) PMID 26486702 ↗
paper Percentage of seroconversion to all (ID 14% vs IM 15%; P = .8) or at least 1 (ID 69% vs IM 68%; P = .7) PMID 26486702 ↗
Publications
- Amoah S, Mishina M, Praphasiri P, Cao W, Kim JH, Liepkalns JS, Guo Z, Carney PJ, Chang JC, Fernandez S, Garg S, Beacham L, Holtz TH, Curlin ME, Dawood F, Olsen SJ, Gangappa S, Stevens J, Sambhara S. Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV Infection. J Infect Dis. 2019 Jul 31;220(5):743-751. doi: 10.1093/infdis/jiz205.
- Garg S, Thongcharoen P, Praphasiri P, Chitwarakorn A, Sathirapanya P, Fernandez S, Rungrojcharoenkit K, Chonwattana W, Mock PA, Sukwicha W, Katz JM, Widdowson MA, Curlin ME, Gibbons RV, Holtz TH, Dawood FS, Olsen SJ. Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand. Clin Infect Dis. 2016 Feb 1;62(3):383-391. doi: 10.1093/cid/civ884. Epub 2015 Oct 20.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trivalent Inactivated Split Virion Influenza Vaccine | Vaccine | 15 ug | Intravitreal |
| Subject | Trivalent Inactivated Split Virion Influenza Vaccine | Vaccine | 15 ug | Intramuscular |